Study title: Clinical Implications of Different Image Reconstruction Parameters for Interpretation of Whole-Body PET Studies in Cancer Patients.J Nucl Med 2004; 45:559–566. Heiko Scho¨der, MD1; Yusuf E. Erdi, DSc2; Kenneth Chao, BS1; Mithat Gonen, PhD3; Steven M. Larson, MD1; and Henry W.D. Yeung, MD1.
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Diagnosis | |||||
| Brands: Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: Steripet | |||||
| ATC code: | |||||
| Document link: schulte-1999.pdf | |||||
| Document date: 2014-12-02 | |||||
| Study number: | |||||
| EudraCT number: | |||||
| Scope of study: CLINICAL | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | - | Y | |